StockNews.com Upgrades InfuSystem (NYSE:INFU) to Strong-Buy

InfuSystem (NYSE:INFU) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday.

InfuSystem Trading Up 1.6 %

Shares of INFU opened at $5.55 on Friday. InfuSystem has a 12-month low of $5.28 and a 12-month high of $9.97. The stock’s fifty day simple moving average is $7.65 and its 200-day simple moving average is $7.56. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $116.60 million, a PE ratio of 92.52 and a beta of 1.75.

Hedge Funds Weigh In On InfuSystem

Several hedge funds have recently added to or reduced their stakes in INFU. First Eagle Investment Management LLC lifted its stake in InfuSystem by 25.9% in the fourth quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company’s stock valued at $7,676,000 after buying an additional 186,668 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of InfuSystem by 283.5% in the fourth quarter. JPMorgan Chase & Co. now owns 59,662 shares of the company’s stock worth $504,000 after acquiring an additional 44,106 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of InfuSystem by 150.3% in the fourth quarter. Marshall Wace LLP now owns 53,315 shares of the company’s stock worth $451,000 after acquiring an additional 32,015 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of InfuSystem by 5.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company’s stock worth $3,853,000 after acquiring an additional 21,697 shares in the last quarter. Finally, Barclays PLC increased its holdings in shares of InfuSystem by 300.5% in the third quarter. Barclays PLC now owns 28,597 shares of the company’s stock worth $192,000 after acquiring an additional 21,457 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.